4 weeks Boot Barn and Align Technology have been highlighted as Zacks Bull and Bear of the DayZacks X
4 weeks That Actively Managed Mutual Fund You’re Paying For? It’s Looking Pretty PassiveThe Wall Street Journal X
4 weeks Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of “Moderate Buy” by AnalystsMarketBeat X
4 weeks HC Wainwright Has Lowered Expectations for Summit Therapeutics (NASDAQ:SMMT) Stock PriceMarketBeat X
4 weeks Robert W. Baird Forecasts Strong Price Appreciation for Bio-Techne (NASDAQ:TECH) StockMarketBeat X
4 weeks Robert W. Baird Forecasts Strong Price Appreciation for Carvana (NYSE:CVNA) StockMarketBeat X
4 weeks Clean Harbors (NYSE:CLH) Price Target Lowered to $268.00 at Needham & Company LLCMarketBeat X
4 weeks Sportradar Group AG (NASDAQ:SRAD) Given Consensus Rating of “Moderate Buy” by AnalystsMarketBeat X
4 weeks OPAL Fuels Inc. (NASDAQ:OPAL) Given Average Rating of “Moderate Buy” by BrokeragesMarketBeat X
4 weeks Hudbay Minerals Inc. (NYSE:HBM) Receives Average Recommendation of “Buy” from AnalystsMarketBeat X
4 weeks Central Garden & Pet (NASDAQ:CENTA) Given Average Recommendation of “Buy” by BrokeragesMarketBeat X
4 weeks Wesdome Gold Mines Ltd. (TSE:WDO) Given Consensus Recommendation of “Buy” by BrokeragesMarketBeat X
4 weeks Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of “Buy” by AnalystsMarketBeat X
4 weeks Political Division Costs Companies $2 Billion a Day. Science Suggests Jiu Jitsu Persuasion Is the AnswerInc.com X
4 weeks Jim Cramer on Lam Research Corporation (LRCX): ‘So The Answer Is I Would Buy It’Insider Monkey X
4 weeks Gen Z and young millennial employees are missing the equivalent of one day’s work every week due to mental health concerns, research showsFortune X
4 weeks Lam Research Corporation (LRCX): Institutional Investors Are Shorting This Semiconductor Stock NowInsider Monkey X
4 weeks Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $58.00 at Cantor FitzgeraldMarketBeat X
4 weeks Verra Mobility (NASDAQ:VRRM) Price Target Cut to $25.00 by Analysts at Morgan StanleyMarketBeat X